Neumora Stock Crashes: Depression Drug Trial Fails
neumora Stock Plunges After Depression Drug Trial Fails Shares of Neumora therapeutics Inc.experienced a record-breaking drop after it’s experimental drug, navacaprant, designed to treat major depressive disorder, failed to demonstrate notable advancement in a pivotal late-stage clinical trial. The news sent shockwaves through the market, highlighting the inherent risks in pharmaceutical advancement. The company announced … Read more